The meetings are more frequent, and theres more being asked of patients and what theyre changing. These programs are offered by a variety of different organizations, including government initiatives, academic hospitals and weight loss clinics, private health networks and telemedicine businesses, and some larger health insurance providers
The Centers for Medicare & Medicaid Services (CMS) recently said that broader access to GLP-1 drugs for weight loss could begin in Medicaid as early as May and in Medicare Part D in January 2027, under its BALANCE Model
What began as a targeted therapy for diabetes has rapidly evolved into a mainstream weight management solution, fueled by rising awareness, direct-to-consumer marketing, and strong clinical outcomes
Large, itchy rashes or signs of a skin infection
Similar findings have been observed Pan et al (2024), which noted significant differences between multiple GLP-1 medications compared with placebo for achieving greater than 5%, 10%, and even 15% weight loss
